To build brand visibility, expand network: Dr Lal Pathlabs

Om Manchanda, CEO, Dr Lal PathLabs in an interview to CNBC-TV18 while sharing the details of the IPO said the company would look to enhance brand visibility and to expand network all over India.

The company has a strong presence in the north and east but sees a huge potential and opportunities to grow in south and west too said Manchanda. The penetration of our market in India is still very low, so the company plans to tap this. “Will focus on organic growth in north, central and east,” he said.

Dr Lal Pathlabs, the Delhi-based diagnostic and related healthcare tests & services provider aims to raise up to Rs 638 crore from its IPO that opens today. The price band for the offer has been fixed at Rs 540-550 per share.

The diagnostic chain raised over Rs 191 crore from anchor investors on Monday by selling shares at a price of Rs 550 apiece.